Dr. Smitha Mellacheruvu, MD
111 E 210th St, Hoffheimer 1-- Department of Medical Oncology, Bronx, NY 10467 • +1-281-555-9299
Medical Education: Accredited U.S. Medical School (Class of 2007)
What This Doctor Actually Performs: CMS Medicare Utilization & Bronx Percentiles
NPI #1548330970 • CBSA Regional • Hematology-Oncology
Dr. Smitha Mellacheruvu, MD (NPI #1548330970) practices Hematology-Oncology in Bronx, NY (10467) with sub-specialty concentration in 96 Active CMS HCPCS Codes, recording 20,170 annual CMS services across 157 distinct beneficiaries—placing this practice as a mid-cohort balanced caseload (46.15th Bronx percentile) (-0.36σ vs NY state mean, 60.67th statewide percentile).
Among 6 tracked CMS fee-schedule codes for Dr. Mellacheruvu (averaging 128.5 services per beneficiary), 99214 (Moderate-to-High Complexity Internal Medicine Follow-Up) represents 3% of tracked volume (543 encounters), paired with 99213 (314x).
Uninsured and high-deductible cash patients visiting Dr. Smitha Mellacheruvu in Bronx (10467) face an estimated $232.00 initial evaluation fee at 111 E 210th St, Hoffheimer 1-- Department of Medical Oncology (in-person clinic visits only; 10-minute average reception wait; bedside manner 4.62/5 from 12 verified reports).
Spanning 19 years of clinical practice following 2007 graduation from medical training, Dr. Smitha Mellacheruvu integrates 96 Active CMS HCPCS Codes diagnostics for Bronx metro patients.
Compared against Bronx, NY Hematology-Oncology peers
20,170 annual services across 157 beneficiaries
Standard deviations from NY Hematology-Oncology mean utilization
Top Billed HCPCS/CPT Procedures & GPCI Self-Pay Cash Benchmarks
| HCPCS | Clinical Procedure Description | Annual Volume | Local Pct | Est. Cash Range |
|---|---|---|---|---|
| 99214 | Moderate-to-High Complexity Internal Medicine Follow-Up | 543 | 46.15th | $48 – $66 |
| 99213 | Established Preventive & Chronic Care Visit | 314 | 45.15th | $37 – $52 |
| 93000 | In-Office 12-Lead Resting Electrocardiogram | 157 | 42.15th | $25 – $40 |
| G0439 | Annual Preventive Wellness & Cardiometabolic Risk Assessment | 121 | 51.15th | $57 – $78 |
| 99204 | Comprehensive New Patient Internal Medicine Diagnostic Visit | 72 | 49.15th | $67 – $92 |
| 96372 | Therapeutic Subcutaneous/Intramuscular Injection Administration (96 HCPCS billing breadth) | 18,964 | 46.15th | $45 – $65 |
Are you Dr. Smitha Mellacheruvu? Embed your Official DotMD Verification Badge (0-JS SVG)
Paste this lightweight SVG snippet onto your clinic bio page in Bronx, NY:
<a href="https://dotmd.com/doctors/smitha-mellacheruvu-md-bronx-ny-1548330970" title="Dr. Smitha Mellacheruvu, MD - Verified CMS Utilization on DotMD"><img src="https://dotmd.com/badges/npi/1548330970.svg" alt="Dr. Smitha Mellacheruvu Hematology-Oncology Badge" width="280" height="72" /></a>
Dr. Smitha Mellacheruvu, MD Fair Cash-Pay & Waiting-Room Scorecard
| Metric | Verified Benchmark | Source |
|---|---|---|
| Dr. Mellacheruvu National Provider Identifier | NPI #1548330970 (MD) | CMS NPPES Registry (10467) |
| Dr. Mellacheruvu Bronx CMS Volume Rank | 46.15th Pct (20,170 CMS svcs; Z -0.359σ) | CMS Medicare Part B (NY Hematology-Oncology) |
| Fair Cash-Pay New-Patient Benchmark | $232.00 (CPT 99204 GPCI Benchmark) | CMS Geographic Practice Cost Index (Bronx, NY) |
| Waiting-Room Wait Time & Cash Friendliness | $232.00 avg paid • 10 min lobby wait | 12 Anonymous Patient Reports |
| Listens Without Rushing & Modern Protocol Score | 4.62/5 Listening • 4.73/5 Modern Labs | CMS Provider Practice Cohort |
“Waiting Room” Patient Reality Scorecard
Ask our AI Specialists anything about Dr. Smitha Mellacheruvu
Other High-Volume Hematology-Oncology Specialists in Bronx, NY
Ranked strictly by CMS Medicare volumeDr. Mellacheruvu Waiting-Room Q&A & Patient Experience Logs
Anonymous patient-submitted wait times, cash visit fees, and bedside manner discussions in Bronx, NY.
Share your self-pay visit cost and lobby wait time—no account, email, or IP stored.
Filter Dr. Smitha Mellacheruvu community threads and patient logs by age, biological sex, dosage, and treatment duration.